My ePortfolio Register   
Filter results by:

Showing: Treatments / Drug development

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 / https://doi.org/10.3332/ecancer.2017.770

Conference Report: Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai

Abstract | Full Article | PDF Published: 02 Nov 2016 / https://doi.org/10.3332/ecancer.2016.689

Clinical Study: Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent

Abstract | Full Article | PDF Published: 12 Oct 2016 / https://doi.org/10.3332/ecancer.2016.680

Conference Report: Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina

Abstract | Full Article | PDF | Spanish Published: 06 Sep 2016 / https://doi.org/10.3332/ecancer.2016.672

Review: Targeted therapies and immunotherapy in non-small-cell lung cancer

Abstract | Full Article | PDF Published: 23 Jun 2016 / https://doi.org/10.3332/ecancer.2016.648

Conference Report: Highlights from the Tenth European Breast Cancer Conference (EBCC10), Amsterdam, 9–11 March 2016

Abstract | Full Article | PDF Published: 03 Jun 2016 / https://doi.org/10.3332/ecancer.2016.644

Clinical Study: Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year

Abstract | Full Article | PDF | Spanish Published: 17 Mar 2016 / https://doi.org/10.3332/ecancer.2016.627

Conference Report: Highlights from the 38th SABCS annual meeting, 8th – 12th December 2015, San Antonio, USA

Abstract | Full Article | PDF Published: 02 Feb 2016 / https://doi.org/10.3332/ecancer.2016.618

Clinical Study: Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

Abstract | Full Article | PDF Published: 11 Jan 2016 / https://doi.org/10.3332/ecancer.2016.610

Review: Anti-androgenic effects of flavonols in prostate cancer

Abstract | Full Article | PDF Published: 22 Oct 2015 / https://doi.org/10.3332/ecancer.2015.585



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence